I'm really happy to see all this movement and it's very possible that EMOR is a well run company that is going to flourish, despite my strong distaste for this industry. What I just don't get is how a CBD company has any kind of know-how or infrastructure for developing highly technical medical products like ESS, Manf etc. Yes, they are bringing Ambs on board to help, but ambs doesn't currently have the structure either, although they should know where and how to find it.
mostly just venting and thinking out loud here. Anxious for the update, as we all are. Let's hope it really is this week.
(1)
(0)
Amarantus Bioscience Holdings (AMBS) Stock Research Links